|
Quotes & Info
|
| TZYM > SEC Filings for TZYM > Form 8-K on 12-Jun-2012 | All Recent SEC Filings |
12-Jun-2012
Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders (the "Annual Meeting") of Tranzyme, Inc. (the "Company") was held on June 7, 2012. At the Annual Meeting, the stockholders voted on the following five proposals and cast their votes as described below.
Proposal 1. The individuals listed below were elected at the Annual Meeting to serve a one-year term on the Company's Board of Directors until the annual meeting of stockholders in 2013 and until their respective successors are duly elected and qualified or until their earlier resignation or removal.
BROKER
FOR WITHHELD NON-VOTES
Vipin K. Garg, Ph.D. 14,807,118 2,761 2,110,894
John H. Johnson 14,802,118 7,761 2,110,894
George B. Abercrombie 14,807,118 2,761 2,110,894
Jean-Paul Castaigne, M.D. 14,807,778 2,101 2,110,894
Aaron Davidson 14,805,578 4,301 2,110,894
Anne M. VanLent 14,807,778 2,101 2,110,894
Alex Zisson 14,804,918 4,961 2,110,894
|
Proposal 2. The Company's stockholders approved the non-binding, advisory resolution on the executive compensation of the Company's named executive officers.
BROKER
FOR ABSTAIN AGAINST NON-VOTES
14,785,380 12,422 12,077 2,110,894
|
Proposal 3. The option to hold advisory votes on the executive compensation of the Company's named executive officers on an annual basis received the highest number of votes from the Company's stockholders.
BROKER
1 YEAR 2 YEARS 3 YEARS ABSTAIN NON-VOTES
14,385,380 4,792 22,976 396,731 2,110,894
|
Proposal 4. The Company's stockholders approved the amendment and restatement of the Tranzyme, Inc. 2011 Stock Option and Incentive Plan.
BROKER NON-
FOR ABSTAIN AGAINST VOTES
14,388,011 7,362 414,506 2,110,894
|
Proposal 5. The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for 2012.
14,911,515 3,990 5,268
|
|